PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10867506-2	2000	The IL-5-induced prolongation of eosinophil survival was dose-dependently inhibited by the protein synthesis inhibitor cycloheximide, the DNA-dependent RNA synthesis inhibitor actinomycin D, and the tyrosine kinase inhibitor herbimycin A.	Cycloheximide	119-132	interleukin 5	Rattus norvegicus	4-8	
10867506-2	2000	The IL-5-induced prolongation of eosinophil survival was dose-dependently inhibited by the protein synthesis inhibitor cycloheximide, the DNA-dependent RNA synthesis inhibitor actinomycin D, and the tyrosine kinase inhibitor herbimycin A.	Dactinomycin	176-189	interleukin 5	Rattus norvegicus	4-8	
10867506-2	2000	The IL-5-induced prolongation of eosinophil survival was dose-dependently inhibited by the protein synthesis inhibitor cycloheximide, the DNA-dependent RNA synthesis inhibitor actinomycin D, and the tyrosine kinase inhibitor herbimycin A.	herbimycin	225-237	interleukin 5	Rattus norvegicus	4-8	
10867506-3	2000	The MEK-1 inhibitor PD98059 inhibited IL-5-induced phosphorylation of both p44 and p42 MAP kinases, but the IL-5-induced prolongation of eosinophil survival was not inhibited.	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	20-27	mitogen activated protein kinase kinase 1	Rattus norvegicus	4-9	
10867506-3	2000	The MEK-1 inhibitor PD98059 inhibited IL-5-induced phosphorylation of both p44 and p42 MAP kinases, but the IL-5-induced prolongation of eosinophil survival was not inhibited.	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	20-27	interleukin 5	Rattus norvegicus	38-42	
10867506-3	2000	The MEK-1 inhibitor PD98059 inhibited IL-5-induced phosphorylation of both p44 and p42 MAP kinases, but the IL-5-induced prolongation of eosinophil survival was not inhibited.	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	20-27	mitogen activated protein kinase 3	Rattus norvegicus	75-78	
10867506-4	2000	In contrast, the JAK2 inhibitor AG490 inhibited the IL-5-induced prolongation of eosinophil survival.	alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide	32-37	Janus kinase 2	Rattus norvegicus	17-21	
10867506-4	2000	In contrast, the JAK2 inhibitor AG490 inhibited the IL-5-induced prolongation of eosinophil survival.	alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide	32-37	interleukin 5	Rattus norvegicus	52-56